Cargando…
Killer-cell immunoglobulin-like receptor genotype and haplotype combinations in children treated for acute lymphoblastic leukemia
INTRODUCTION: Acute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children. The factors predisposing to ALL remain mostly unknown. Natural killer (NK) cells are a component of innate immunity. Their role is to eliminate cells that were infected with viruses or underwent a n...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568030/ https://www.ncbi.nlm.nih.gov/pubmed/34764789 http://dx.doi.org/10.5114/ceji.2021.108178 |
_version_ | 1784594347282399232 |
---|---|
author | Kołtan, Sylwia Kołtan, Andrzej Soszyńska, Krystyna Matiakowska, Karolina Morgut-Klimkowska, Małgorzata Grześk, Elżbieta Grześk, Grzegorz Dąbrowska, Anna Urbańczyk, Anna Konieczek, Joanna Styczyński, Jan Haus, Olga Wysocki, Mariusz |
author_facet | Kołtan, Sylwia Kołtan, Andrzej Soszyńska, Krystyna Matiakowska, Karolina Morgut-Klimkowska, Małgorzata Grześk, Elżbieta Grześk, Grzegorz Dąbrowska, Anna Urbańczyk, Anna Konieczek, Joanna Styczyński, Jan Haus, Olga Wysocki, Mariusz |
author_sort | Kołtan, Sylwia |
collection | PubMed |
description | INTRODUCTION: Acute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children. The factors predisposing to ALL remain mostly unknown. Natural killer (NK) cells are a component of innate immunity. Their role is to eliminate cells that were infected with viruses or underwent a neoplastic transformation. The activity of NK cells is regulated by their activating and inhibitory receptors, inter alia killer-cell immunoglobulin-like receptors (KIRs). The available data about a link between the incidence of ALL and KIR genotype are highly inconclusive, and further research is needed to explain whether such a relationship truly exists. The aim of this study was to analyze KIR genotype and haplotype combinations in children treated for ALL. MATERIAL AND METHODS: The study included 49 children diagnosed with ALL at 1.2-19.8 years of age. The control group was composed of 43 healthy subjects aged between 1.2 and 21.9 years. DNA was isolated using QIAamp DNA Mini kits. KIR genotypes were identified by a polymerase chain reaction (PCR) with sequence-specific primers (SSPs). The analysis also included KIR haplotype combinations: AA, AB and BB. RESULTS: Patients with ALL and controls did not differ significantly in the frequencies of individual KIR genes and haplotypes. However, the overall frequency of all 6 activating KIR genes in patients with ALL was significantly higher than in the controls (24.5% vs. 4.7%, p = 0.019). CONCLUSIONS: The findings presented here imply that individual KIR genes do not play a significant role in the pathogenesis of ALL. Nevertheless, a higher number of activating KIR genes may constitute a risk factor for this malignancy. |
format | Online Article Text |
id | pubmed-8568030 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-85680302021-11-10 Killer-cell immunoglobulin-like receptor genotype and haplotype combinations in children treated for acute lymphoblastic leukemia Kołtan, Sylwia Kołtan, Andrzej Soszyńska, Krystyna Matiakowska, Karolina Morgut-Klimkowska, Małgorzata Grześk, Elżbieta Grześk, Grzegorz Dąbrowska, Anna Urbańczyk, Anna Konieczek, Joanna Styczyński, Jan Haus, Olga Wysocki, Mariusz Cent Eur J Immunol Clinical Immunology INTRODUCTION: Acute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children. The factors predisposing to ALL remain mostly unknown. Natural killer (NK) cells are a component of innate immunity. Their role is to eliminate cells that were infected with viruses or underwent a neoplastic transformation. The activity of NK cells is regulated by their activating and inhibitory receptors, inter alia killer-cell immunoglobulin-like receptors (KIRs). The available data about a link between the incidence of ALL and KIR genotype are highly inconclusive, and further research is needed to explain whether such a relationship truly exists. The aim of this study was to analyze KIR genotype and haplotype combinations in children treated for ALL. MATERIAL AND METHODS: The study included 49 children diagnosed with ALL at 1.2-19.8 years of age. The control group was composed of 43 healthy subjects aged between 1.2 and 21.9 years. DNA was isolated using QIAamp DNA Mini kits. KIR genotypes were identified by a polymerase chain reaction (PCR) with sequence-specific primers (SSPs). The analysis also included KIR haplotype combinations: AA, AB and BB. RESULTS: Patients with ALL and controls did not differ significantly in the frequencies of individual KIR genes and haplotypes. However, the overall frequency of all 6 activating KIR genes in patients with ALL was significantly higher than in the controls (24.5% vs. 4.7%, p = 0.019). CONCLUSIONS: The findings presented here imply that individual KIR genes do not play a significant role in the pathogenesis of ALL. Nevertheless, a higher number of activating KIR genes may constitute a risk factor for this malignancy. Termedia Publishing House 2021-08-07 2021 /pmc/articles/PMC8568030/ /pubmed/34764789 http://dx.doi.org/10.5114/ceji.2021.108178 Text en Copyright © 2021 Termedia https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) ) |
spellingShingle | Clinical Immunology Kołtan, Sylwia Kołtan, Andrzej Soszyńska, Krystyna Matiakowska, Karolina Morgut-Klimkowska, Małgorzata Grześk, Elżbieta Grześk, Grzegorz Dąbrowska, Anna Urbańczyk, Anna Konieczek, Joanna Styczyński, Jan Haus, Olga Wysocki, Mariusz Killer-cell immunoglobulin-like receptor genotype and haplotype combinations in children treated for acute lymphoblastic leukemia |
title | Killer-cell immunoglobulin-like receptor genotype and haplotype combinations in children treated for acute lymphoblastic leukemia |
title_full | Killer-cell immunoglobulin-like receptor genotype and haplotype combinations in children treated for acute lymphoblastic leukemia |
title_fullStr | Killer-cell immunoglobulin-like receptor genotype and haplotype combinations in children treated for acute lymphoblastic leukemia |
title_full_unstemmed | Killer-cell immunoglobulin-like receptor genotype and haplotype combinations in children treated for acute lymphoblastic leukemia |
title_short | Killer-cell immunoglobulin-like receptor genotype and haplotype combinations in children treated for acute lymphoblastic leukemia |
title_sort | killer-cell immunoglobulin-like receptor genotype and haplotype combinations in children treated for acute lymphoblastic leukemia |
topic | Clinical Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568030/ https://www.ncbi.nlm.nih.gov/pubmed/34764789 http://dx.doi.org/10.5114/ceji.2021.108178 |
work_keys_str_mv | AT kołtansylwia killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia AT kołtanandrzej killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia AT soszynskakrystyna killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia AT matiakowskakarolina killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia AT morgutklimkowskamałgorzata killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia AT grzeskelzbieta killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia AT grzeskgrzegorz killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia AT dabrowskaanna killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia AT urbanczykanna killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia AT konieczekjoanna killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia AT styczynskijan killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia AT hausolga killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia AT wysockimariusz killercellimmunoglobulinlikereceptorgenotypeandhaplotypecombinationsinchildrentreatedforacutelymphoblasticleukemia |